Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

Fig. 2

A The number of overlapping 25 targets from Avena sativa between SEA and STP. B The number of overlapping 668 targets from gut microbiota between SEA and STP. C The number of overlapping 23 targets between Avena sativa and gut microbiota. D The number of overlapping 16 targets via intersecting targets of Avena sativa and gut microbiota against NAFLD

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us